Neogenomics Inc
NASDAQ:NEO
Neogenomics Inc
Cash from Investing Activities
Neogenomics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neogenomics Inc
NASDAQ:NEO
|
Cash from Investing Activities
$67.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Investing Activities
-$131.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is Neogenomics Inc's Cash from Investing Activities?
Cash from Investing Activities
67.5m
USD
Based on the financial report for Mar 31, 2024, Neogenomics Inc's Cash from Investing Activities amounts to 67.5m USD.
What is Neogenomics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
453%
Over the last year, the Cash from Investing Activities growth was 453%.